Clinical assessment of arrhythmias in tetralogy of Fallot

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 2, 2010, Pages 189-197

  Le Gloan, Laurianne ^a   Guerin, Patrice ^b   Mercier, Lise Andrée ^a   Abbey, Sélim ^b   Dore, Annie ^a   Marcotte, François ^a   Ibrahim, Reda ^a   Poirier, Nancy C ^a   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

arrhythmias; implantable cardioverter defibrillators; programmed ventricular stimulation; risk stratification; sudden cardiac death; tetralogy of Fallot

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; DOFETILIDE; SOTALOL;

AUTONOMIC NERVOUS SYSTEM; CARDIAC IMAGING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DEMOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FALLOT TETRALOGY; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; PREVALENCE; PROGNOSIS; QRS COMPLEX; QT INTERVAL; REVIEW; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; THREE DIMENSIONAL IMAGING; UNSPECIFIED SIDE EFFECT; AGING; CATHETER ABLATION; DEFIBRILLATOR; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; RISK FACTOR;

AGING; ARRHYTHMIAS, CARDIAC; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; HUMANS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TETRALOGY OF FALLOT;

EID: 77951914110     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.156     Document Type: Review

References (65)

1. Lillehei CW, Cohen M, Warden HE, Varco RL. The direct-vision intracardiac correction of congenital anomalies by controlled cross circulation; results in thirty-two patients with ventricular septal defects, tetralogy of Fallot, and atrioventricularis communis defects. Surgery 38(1), 11-29 (1955).
2. Murphy JG, Gersh BJ, Mair DD et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N. Engl. J. Med. 329(9), 593-599 (1993).
3. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J. Am. Coll. Cardiol. 32(1), 245-251 (1998).
4. Friedli B. Arrhythmia after surgery for congenital cardiopathies. What studies? What treatment? Arch. Mal. Coeur. Vaiss. 89(3), 351-357 (1996).
5. Horowitz LN, Alexander JA, Edmunds LH Jr. Postoperative right bundle branch block: identification of three levels of block. Circulation 62(2), 319-328 (1980).
6. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 92(2), 231-237 (1995).
7. Friedli B. Electrophysiological follow-up of tetralogy of Fallot. Pediatr. Cardiol. 20(5), 326-330 (1999).
8. Hokanson JS, Moller JH. Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot. Am. J. Cardiol. 87(11), 1271-1277 (2001).
9. Friedli B, Bolens M, Taktak M. Conduction disturbances after correction of tetralogy of Fallot: are electrophysiologic studies of prognostic value? J. Am. Coll. Cardiol. 11(1), 162-165 (1988).
10. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 51(21), e1-e62 (2008).
11. Sarubbi B, Pacileo G, Ducceschi V et al. Arrhythmogenic substrate in young patients with repaired tetralogy of Fallot: role of an abnormal ventricular repolarization. Int. J. Cardiol. 72(1), 73-82 (1999).
12. Roos-Hesselink J, Perlroth MG, McGhie J, Spitaels S. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic findings. Circulation 91(8), 2214-2219 (1995).
13. Gatzoulis MA, Balaji S, Webber SA et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 356(9234), 975-981 (2000).
14. Engelfriet P, Boersma E, Oechslin E et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur. Heart J. 26(21), 2325-2333 (2005).
15. Harrison DA, Siu SC, Hussain F et al. Sustained atrial arrhythmias in adults late after repair of tetralogy of Fallot. Am. J. Cardiol. 87(5), 584-588 (2001).
16. Wessel HU, Bastanier CK, Paul MH et al. Prognostic significance of arrhythmia in tetralogy of Fallot after intracardiac repair. Am. J. Cardiol. 46(5), 843-848 (1980).
17. Hallioglu O, Aytemir K, Celiker A. The significance of P wave duration and P wave dispersion for risk assessment of atrial tachyarrhythmias in patients with corrected tetralogy of Fallot. Ann. Noninvasive Electrocardiol. 9(4), 339-344 (2004).
18. Wells R, Khairy P, Harris L, Anderson CC, Balaji S. Dofetilide for atrial arrhythmias in congenital heart disease: a multicenter study. Pacing Clin. Electrophysiol. 32(10), 1313-1318 (2009).
19. Hoyer AW, Balaji S. The safety and efficacy of ibutilide in children and in patients with congenital heart disease. Pacing Clin. Electrophysiol. 30(8), 1003-1008 (2007).
20. Khairy P, Stevenson WG. Catheter ablation in tetralogy of Fallot. Heart Rhythm 6(7), 1069-1074 (2009).
21. Stulak JM, Dearani JA, Puga FJ et al. Right-sided maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann. Thorac. Surg. 81(5), 1780-1784; discussion 1784-1785 (2006).
22. Deanfield JE, McKenna WJ, Presbitero P et al. Ventricular arrhythmia in unrepaired and repaired tetralogy of Fallot. Relation to age, timing of repair, and haemodynamic status. Br. Heart J. 52(1), 77-81 (1984).
23. Zeppenfeld K, Schalij MJ, Bartelings MM et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 116(20), 2241-2252 (2007).
24. Zeltser I, Gaynor JW, Petko M et al. The roles of chronic pressure and volume overload states in induction of arrhythmias: an animal model of physiologic sequelae after repair of tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 130(6), 1542-1548 (2005).
25. Khairy P, Dore A, Poirier N et al. Risk stratification in surgically repaired tetralogy of Fallot. Expert Rev. Cardiovasc. Ther. 7(7), 755-762 (2009).
26. Chin AJ, Murphy JD. Identification of coronary sinus septal defect (unroofed coronary sinus) by color Doppler echocardiography. Am. Heart J. 124(6), 1655 (1992).
27. Dietl CA, Cazzaniga ME, Dubner SJ et al. Life-threatening arrhythmias and RV dysfunction after surgical repair of tetralogy of Fallot. Comparison between transventricular and transatrial approaches. Circulation 90(5 Pt 2), II7-II12 (1994).
28. Khairy P, Marelli AJ. Clinical use of electrocardiography in adults with congenital heart disease. Circulation 116(23), 2734-2746 (2007).
29. Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary. J. Am. Coll. Cardiol. 52(23), 1890-1947 (2008).
30. Cullen S, Celermajer DS, Franklin RC, Hallidie-Smith KA, Deanfield JE. Prognostic significance of ventricular arrhythmia after repair of tetralogy of Fallot: a 12-year prospective study. J. Am. Coll. Cardiol. 23(5), 1151-1155 (1994).
31. Khairy P, Harris L, Landzberg MJ et al. Implantable cardioverter- defibrillators in tetralogy of Fallot. Circulation 117(3), 363-370 (2008).
32. Khairy P, Landzberg MJ, Gatzoulis MA et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 109(16), 1994-2000 (2004).
33. Balaji S, Lau YR, Case CL, Gillette PC. QRS prolongation is associated with inducible ventricular tachycardia after repair of tetralogy of Fallot. Am. J. Cardiol. 80(2), 160-163 (1997).
34. Gatzoulis MA, Till JA, Redington AN. Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot. The substrate for malignant ventricular tachycardia? Circulation 95(2), 401-404 (1997).
35. Daliento L, Caneve F, Turrini P et al. Clinical significance of high-frequency, low-amplitude electrocardiographic signals and QT dispersion in patients operated on for tetralogy of Fallot. Am. J. Cardiol. 76(5), 408-411 (1995).
36. Daliento L, Rizzoli G, Menti L et al. Accuracy of electrocardiographic and echocardiographic indices in predicting life threatening ventricular arrhythmias in patients operated for tetralogy of Fallot. Heart 81(6), 650-655 (1999).
37. Cheung MM, Weintraub RG, Cohen RJ et al. T wave alternans threshold late after repair of tetralogy of Fallot. J. Cardiovasc. Electrophysiol. 13(7), 657-661 (2002).
38. Brachmann J, Schols W, Beyer T et al. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias. Eur. Heart J. 14(Suppl. H), 85-87 (1993).
39. Perloff JK, Middlekauf HR, Child JS et al. Usefulness of post-ventriculotomy signal averaged electrocardiograms in congenital heart disease. Am. J. Cardiol. 98(12), 1646-1651 (2006).
40. Brili S, Aggeli C, Gatzoulis K et al. Echocardiographic and signal averaged ECG indices associated with non-sustained ventricular tachycardia after repair of tetralogy of Fallot. Heart 85(1), 57-60 (2001).
41. Russo G, Folino AF, Mazzotti E, Rebellato L, Daliento L. Comparison between QRS duration at standard ECG and signal-averaging ECG for arrhythmic risk stratification after surgical repair of tetralogy of Fallot. J. Cardiovasc. Electrophysiol. 16(3), 288-292 (2005).
42. Omeroglu RE, Olgar S, Nisli K. Signal-averaged electrocardiogram may be a beneficial prognostic procedure in the postoperative follow-up tetralogy of Fallot patients to determine the risk of ventricular arrhythmias. Pediatr. Cardiol. 28(3), 208-212 (2007).
43. Khairy P. Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective. Nat. Clin. Pract. Cardiovasc. Med. 4(6), 292-293 (2007).
44. Wessel HU, Paul MH. Exercise studies in tetralogy of Fallot: a review. Pediatr. Cardiol. 20(1), 39-47 (1999).
45. Garson A Jr, Gillette PC, Gutgesell HP, McNamara DG. Stress-induced ventricular arrhythmia after repair of tetralogy of Fallot. Am. J. Cardiol. 46(6), 1006-1012 (1980).
46. van den Berg J, de Bie S, Meijboom FJ et al. Changes during exercise of ECG intervals related to increased risk for ventricular arrhythmia in repaired tetralogy of Fallot and their relationship to right ventricular size and function. Int. J. Cardiol. 124(3), 332-338 (2008).
47. McLeod KA, Hillis WS, Houston AB et al. Reduced heart rate variability following repair of tetralogy of Fallot. Heart 81(6), 656-660 (1999).
48. Daliento L, Folino AF, Menti L et al. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot. J. Am. Coll. Cardiol. 38(7), 2043-2047 (2001).
49. Davos CH, Davlouros PA, Wensel R et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation 106(12 Suppl. 1), 169-175 (2002).
50. Knauth AL, Gauvreau K, Powell AJ et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 94(2), 211-216 (2008).
51. Katz NM, Blackstone EH, Kirklin JW, Pacifico AD, Bargeron LM Jr. Late survival and symptoms after repair of tetralogy of Fallot. Circulation 65(2), 403-410 (1982).
52. Harrison DA, Harris L, Siu SC et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J. Am. Coll. Cardiol. 30(5), 1368-1373 (1997).
53. Ghai A, Silversides C, Harris L et al. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J. Am. Coll. Cardiol. 40(9), 1675-1680 (2002).
54. Wald RM, Haber I, Wald R et al. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 119(10), 1370-1377 (2009).
55. Babu-Narayan SV, Kilner PJ, Li W et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 113(3), 405-413 (2006).
56. Marcotte F, Poirier N, Pressacco J et al. Evaluation of adult congenital heart disease by cardiac magnetic resonance imaging. Congenit. Heart Dis. 4(4), 216-230 (2009).
57. Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: a review. Am. Heart J. 151(2), 265-272 (2006).
58. Buechel ER, Dave HH, Kellenberger CJ et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur. Heart J. 26(24), 2721-2727 (2005).
59. van Huysduynen BH, van Straten A, Swenne CA et al. Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume. Eur. Heart J. 26(9), 928-932 (2005).
60. Oosterhof T, Vliegen HW, Meijboom FJ et al. Long-term effect of pulmonary valve replacement on QRS duration in patients with corrected tetralogy of Fallot. Heart 93(4), 506-509 (2007).
61. Harrild DM, Berul CI, Cecchin F et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 119(3), 445-451 (2009).
62. Khairy P. EP challenges in adult congenital heart disease. Heart Rhythm 5(10), 1464-1472 (2008).
63. Therrien J, Siu SC, Harris L et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 103(20), 2489-2494 (2001).
64. Yap SC, Roos-Hesselink JW, Hoendermis ES et al. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur. Heart J. 28(15), 1854-1861 (2007).
65. Berul CI, Van Hare GF, Kertesz NJ et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J. Am. Coll. Cardiol. 51(17), 1685-1691 (2008).